Workflow
PSQ (PSQH)
icon
Search documents
PSQ (PSQH) - 2023 Q4 - Earnings Call Transcript
2024-03-14 15:33
PublicSquare Holdings, Inc. (NYSE:PSQH) Q4 2023 Earnings Conference Call March 14, 2024 9:00 AM ET Company Participants William Kent - Vice President of Investor Relations Michael Seifert - Chairman and Chief Executive Officer Brad Searle - Chief Financial Officer Dusty Wunderlich - President of Credova subsidiary Conference Call Participants Darren Aftahi - ROTH MKM Operator Greetings and welcome to PublicSquare‘s Year End 2023 Earnings Conference Call and Webcast. Please note that this call is being recor ...
PSQ (PSQH) - 2023 Q4 - Annual Report
2024-03-14 12:07
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40457 PSQ Holdings, Inc. (Exact name of registrant as specified in its charter) | Delaware | 86-2062844 | | --- | --- | | (State or oth ...
PSQ (PSQH) - 2023 Q4 - Annual Results
2024-03-14 10:31
Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among PSQ HOLDINGS, INC., as Buyer CELLO MERGER SUB, INC., as Merger Sub CREDOVA HOLDINGS, INC., as the Company and SAMUEL L. PAUL, as Seller Representative Dated as of March 13, 2024 Table of Contents | | | Page | | --- | --- | --- | | ARTICLE I THE MERGER | | - 2 - | | 1.1. | The Merger | - 2 - | | 1.2. | Effective Time | - 2 - | | 1.3. | Closing | - 2 - | | 1.4. | Effect of the Merger | - 2 - | | 1.5. | Merger Consideration | - 2 - | | 1.6 ...
PSQ (PSQH) - 2023 Q3 - Quarterly Report
2023-11-14 21:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40457 PSQ Holdings, Inc. (Exact name of registrant as specified in its charter) | Delaware | 86-2062844 | | --- | --- | | (Sta ...
PSQ (PSQH) - 2023 Q2 - Quarterly Report
2023-08-09 12:50
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to PSQ HOLDINGS, INC. (F/K/A COLOMBIER ACQUISTION CORP.) (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of incorporation) 222 Lakeview ...
PSQ (PSQH) - 2023 Q1 - Quarterly Report
2023-05-12 20:16
Part I. Financial Information [Item 1. Interim Condensed Consolidated Financial Statements](index=4&type=section&id=Item%201.%20Interim%20Condensed%20Consolidated%20Financial%20Statements) This section presents the unaudited interim financial statements, including balance sheets, statements of operations, and cash flows, detailing the company's financial position and a **net loss of $1.65 million** for the quarter [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) As of March 31, 2023, total assets increased slightly to **$176.3 million**, while total liabilities rose to **$10.8 million**, and the stockholders' deficit widened to **$7.9 million** Condensed Consolidated Balance Sheets (Unaudited) | | March 31, 2023 | December 31, 2022 | | :--- | :--- | :--- | | **Assets** | | | | Cash | $1,792,862 | $195,339 | | Marketable securities held in Trust Account | $174,396,858 | $174,948,027 | | **Total Assets** | **$176,325,225** | **$175,322,752** | | **Liabilities & Stockholders' Deficit** | | | | Total current liabilities | $2,276,848 | $1,110,527 | | Warrant liabilities | $2,519,000 | $1,030,500 | | Total liabilities | $10,833,348 | $8,178,527 | | Class A common stock subject to possible redemption | $173,367,397 | $173,034,002 | | Total Stockholders' Deficit | ($7,875,520) | ($5,889,777) | | **TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT** | **$176,325,225** | **$175,322,752** | [Condensed Consolidated Statements of Operations](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Operations) For Q1 2023, the company reported a **net loss of $1.65 million**, a significant shift from **$2.59 million net income** in Q1 2022, primarily due to increased operating costs and negative warrant fair value changes Condensed Consolidated Statements of Operations (Unaudited) | | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 | | :--- | :--- | :--- | | Operating and formation costs | $1,549,416 | $292,360 | | Loss from operations | ($1,549,416) | ($292,360) | | Interest earned on marketable securities held in Trust Account | $1,838,129 | $11,135 | | Change in fair value of warrant liabilities | ($1,488,500) | $2,866,252 | | Provision for income taxes | ($452,561) | — | | **Net (loss) income** | **($1,652,348)** | **$2,585,027** | | **Basic and diluted net (loss) income per share, Class A** | **($0.08)** | **$0.12** | [Condensed Consolidated Statements of Cash Flows](index=7&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Net cash used in operating activities was **$791,775** for Q1 2023, offset by **$2.39 million** from investing activities, resulting in a **$1.6 million** net increase in cash Cash Flow Summary (Unaudited) | | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 | | :--- | :--- | :--- | | Net cash used in operating activities | ($791,775) | ($383,074) | | Net cash provided by investing activities | $2,389,298 | $0 | | **Net Change in Cash** | **$1,597,523** | **($383,074)** | | Cash – Beginning | $195,339 | $841,226 | | **Cash – Ending** | **$1,792,862** | **$458,152** | [Notes to Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) These notes detail the company's status as a blank check company, its pending merger with PublicSq., and liquidity concerns, including the **September 11, 2023** business combination deadline and deferred underwriting fees - The Company is a blank check company formed to effectuate a business combination, with all activity related to its formation, IPO, and target identification[22](index=22&type=chunk)[24](index=24&type=chunk) - On **February 27, 2023**, the Company entered into a Merger Agreement with PSQ Holdings, Inc. d/b/a PublicSq[42](index=42&type=chunk) - The Company faces mandatory liquidation if a Business Combination is not completed by **September 11, 2023**, raising substantial doubt about its going concern ability[39](index=39&type=chunk)[47](index=47&type=chunk) - A deferred underwriting fee of **$6,037,500** is payable from the Trust Account only upon completion of a Business Combination[30](index=30&type=chunk)[100](index=100&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=32&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses the Q1 2023 financial results, highlighting a **net loss of $1.65 million** due to increased operating costs and warrant fair value changes, and addresses the pending PublicSq. merger and going concern risks Results of Operations Summary | | Three Months Ended March 31, 2023 | Three Months Ended March 31, 2022 | | :--- | :--- | :--- | | **Net (Loss) / Income** | **($1,652,348)** | **$2,585,027** | | **Key Drivers** | | | | Operating Costs | $1,549,416 | $292,360 | | Change in Fair Value of Warrant Liabilities | ($1,488,500) | $2,866,252 | | Interest Earned on Trust Account | $1,838,129 | $11,135 | - As of March 31, 2023, the company held **$1,792,862** in cash outside the trust account and **$174,396,858** in marketable securities within the Trust Account[153](index=153&type=chunk)[155](index=155&type=chunk) - The **September 11, 2023**, deadline for a Business Combination raises substantial doubt about the company's going concern ability if not met, potentially leading to mandatory liquidation[159](index=159&type=chunk) - A definitive Merger Agreement with PublicSq. was entered on **February 27, 2023**, automatically extending the business combination completion window to **September 11, 2023**[163](index=163&type=chunk)[173](index=173&type=chunk) [Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk](index=39&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20Regarding%20Market%20Risk) As a smaller reporting company, Colombier Acquisition Corp. is not required to provide the information for this item - The company is a smaller reporting company and is not required to provide the information for this Item[181](index=181&type=chunk) [Item 4. Controls and Procedures](index=39&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded that disclosure controls and procedures were ineffective as of March 31, 2023, due to a material weakness in accounting for complex financial instruments, with remediation plans underway - The CEO and CFO concluded that disclosure controls and procedures were **not effective** as of March 31, 2023[183](index=183&type=chunk) - This ineffectiveness stemmed from a material weakness in internal control over financial reporting related to complex financial instruments accounting[183](index=183&type=chunk) - Management plans to remediate this weakness by enhancing review processes, improving access to accounting literature, and consulting third-party professionals[184](index=184&type=chunk) Part II. Other Information [Item 1. Legal Proceedings](index=40&type=section&id=Item%201.%20Legal%20Proceedings) The company reports no legal proceedings to disclose - The company has no legal proceedings to report[188](index=188&type=chunk) [Item 1A. Risk Factors](index=40&type=section&id=Item%201A.%20Risk%20Factors) There have been no material changes to the risk factors previously disclosed in the Annual Report on Form 10-K - There have been no material changes to the risk factors disclosed in the company's Annual Report on Form 10-K[189](index=189&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=40&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section details **$172.5 million** in gross proceeds from the IPO and **$5.7 million** from private placement warrants, with **$172.5 million** deposited into the Trust Account - The IPO and over-allotment option generated **$172.5 million** in gross proceeds from the sale of **17,250,000** units[190](index=190&type=chunk)[193](index=193&type=chunk) - The Sponsor purchased **5,700,000** Private Placement Warrants for **$5.7 million**[191](index=191&type=chunk)[193](index=193&type=chunk) - A total of **$172.5 million** from gross proceeds was placed in the Trust Account[193](index=193&type=chunk) [Item 3. Defaults Upon Senior Securities](index=41&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) The company reports no defaults upon senior securities - None[196](index=196&type=chunk) [Item 4. Mine Safety Disclosures](index=41&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) The company reports no mine safety disclosures - None[196](index=196&type=chunk) [Item 5. Other Information](index=41&type=section&id=Item%205.%20Other%20Information) The company reports no other information - None[196](index=196&type=chunk) [Item 6. Exhibits](index=41&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including the Merger Agreement with PublicSq. and various support agreements and officer certifications - Exhibits filed include the Merger Agreement with PSQ Holdings, Inc., Sponsor Support Agreement, and officer certifications[197](index=197&type=chunk) Part III. Signatures [Signatures](index=42&type=section&id=Signatures) The report was duly signed by Omeed Malik, CEO, and Joe Voboril, CFO, on **May 12, 2023** - The report was signed on **May 12, 2023**, by Omeed Malik (CEO) and Joe Voboril (CFO)[201](index=201&type=chunk)
PSQ (PSQH) - 2022 Q4 - Annual Report
2023-03-24 20:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40457 Colombier Acquisition Corp. (Exact name of registrant as specified in its charter) | Delaware | 86-2062844 | | --- | --- | | (State or ot ...
PSQ (PSQH) - 2022 Q3 - Quarterly Report
2022-11-02 20:10
Table of Contents FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40457 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 COLOMBIER ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 86-2062844 (State o ...
PSQ (PSQH) - 2022 Q2 - Quarterly Report
2022-08-08 20:24
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarter ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-40457 COLOMBIER ACQUISITION CORP. (Exact Name of Registrant as Specified in Its Charter) Delaware 86-2062844 (State or oth ...
PSQ (PSQH) - 2022 Q1 - Quarterly Report
2022-05-09 20:08
IPO and Fundraising - The company completed its Initial Public Offering (IPO) on June 11, 2021, generating gross proceeds of $150 million from the sale of 15,000,000 Units at $10.00 per Unit[124]. - An additional 2,250,000 Units were sold due to the underwriters' over-allotment option, generating total gross proceeds of $22.5 million[125]. Financial Position - As of March 31, 2022, the company had marketable securities held in the Trust Account amounting to $172,517,647, which includes $17,647 of interest income[129]. - The company has no long-term debt or off-balance sheet arrangements as of March 31, 2022[134]. Income and Expenses - For the three months ended March 31, 2022, the company reported a net income of $2,585,027, primarily from interest earned on marketable securities and changes in fair value of warrant liabilities[122]. - The company incurred $30,000 in fees for office space and administrative services for the three months ended March 31, 2022[135]. - Cash used in operating activities for the three months ended March 31, 2022, was $383,074, with net income affected by interest and changes in fair value of warrant liabilities[127]. Business Combination and Future Outlook - The company intends to use substantially all funds in the Trust Account to complete its Business Combination[130]. - If the Business Combination is not consummated, the company may need to raise additional capital, which raises substantial doubt about its ability to continue as a going concern[133]. - The company has not generated any operating revenues to date and does not expect to do so until after the completion of its Business Combination[121].